1 / 6

Viral Vector and Plasmid DNA Manufacturing Market Share Industry Forecast 2019-2026

According to the current analysis of Reports and Data, the global Viral Vector and Plasmid DNA manufacturing market is expected to reach USD 2,493.80 million by the year 2026, with a CAGR of 23.8%

VijayKurane
Download Presentation

Viral Vector and Plasmid DNA Manufacturing Market Share Industry Forecast 2019-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Viral Vector and Plasmid DNA Manufacturing Market To Reach USD 2,493.80 Million By 2026

  2. Market Summary The rise in prevalence of cancer, inherited disorders, viral infections, Alzheimer’s, Parkinson’s, rheumatoid arthritis are the major growth factors for viral vector and plasmid DNA manufacturing market. Besides, the growing number of gene modified therapies like Yescarta and Kymriah are also fueling the market growth. According to the current analysis of Reports and Data, the global Viral Vector and Plasmid DNA manufacturing market is expected to reach USD 2,493.80 million by the year 2026, with a CAGR of 23.8% during the forecast period.  • Further key findings from the report suggest • Increasing acceptance of viral vector-based advanced treatments is likely to drive the segment in viral vector and plasmid DNA manufacturing market. The significant share is due to the use of adeno associated virus, lentivirus, and others. • By application, cancer is expected to account for the largest share of the market, followed by genetic disorder segment, which occupied a market share of around 33.3% in 2017. www.reportsanddata.com

  3. Market Summary Key Players: FUJIFILM Diosynth Biotechnologies, Kaneka Eurogentec S.A, Fin vector, Spark therapeutics, Cobra biologics, Cell and gene therapy catapult, Renova Therapeutics, Shenzhen SiBionoGeneTech Co., Ltd, Thermo Fisher Scientific, Inc, 4D Molecular Therapeutics Segmentation: • By Product (Revenue, USD Million; 2016-2026) • Plasmid DNA • Viral Vectors • Non-viral Vectors • By Workflow (Revenue, USD Million, 2014 - 2026) • Upstream Processing • Vector Amplification & Expansion • Vector Recovery/Harvesting • Downstream Processing • Purification • Fill-finish Here, you can avail sample PDF pages and 30 mins free consultation: https://www.reportsanddata.com/sample-enquiry-form/1938 www.reportsanddata.com

  4. Market Summary By Disease (Revenue, USD Million; 2016-2026) Cancer Inherited Disorders Viral Infections Others By Application (Revenue, USD Million, 2016-2026) Antisense, RNAi, & Molecular Therapy Vaccinology Regional Outlook for Viral Vector and Plasmid DNA Manufacturing Market analyses the following geographies: North America (United States, Canada, and Mexico) Europe (Germany, France, UK, Russia, and Italy) Asia-Pacific (China, Japan, Korea, India, and Southeast Asia) South America (Brazil, Argentina, Colombia, etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa) Grab Your Report at an Impressive Discount! Please Click Here @https://www.reportsanddata.com/discount-enquiry-form/1938 www.reportsanddata.com

  5. The report emphasizes the following key questions: Q.1.What are the most lucrative and promising growth prospects for the market? Q.2.Which sectors are expected to deliver a high growth rate and which industry aspects come into play in this advancement? Q.3.Which geographies are estimated to exhibit the highest growth and the underlying causes? Q.4.Which factors are impacting the future of the market and what are the driving factors? Q.5.What are the hurdles and challenges curtailing the industry’s growth in the forecast period? www.reportsanddata.com

  6. About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related